NRIX vs TT · rev $54.5M vs P/E 36, rev $21.32B
Nurix Therapeutics Inc (NRIX) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
NRIX currently screens at market cap $1.77B. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the NRIX and TT stock pages for the full models.
Not investment advice.